Bit of news in the radiopharmaceutical space. Would like to know what NOX are planning with Lupin.
https://endpts.com/after-big-pharma-sparked-interest-in-the-us-ablaze-looks-to-bring-radiopharmaceuticals-overseas/
Seems to have been a sell down since the on/off grant government led fiasco. Not sure why people are in a rush to get out, only a few months until news on interim trial results. I would’ve thought any continuation of phase 1 results in DARRT-2 would have NOX seriously undervalued and in line for a re-rate. I suppose poor results would have these sellers looking like winners though.
DYOR, GLTAH
Investor Video Noxopharm 2021 AGM, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
-0.017(14.8%) |
Mkt cap ! $28.63M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 9.8¢ | $70.79K | 680.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25356 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 240399 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |